GGrantIndex
Sort

89,613 grants matching depression

Metabolic Phenotyping in Live Models of Obesity and Diabetes

$709,018
Carol Fuzeti Elias · University Of Michigan At Ann Arbor · U2C · FY2025 · DK

Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid Safety

$709,013
Shanna Babalonis · University Of Kentucky · R01 · FY2023 · DA

Enhanced Linkage of Drug Abusers to Primary Medical Care

$709,007
Jeffrey H Samet · Boston Medical Center · R01 · FY2008 · DA

Identity of late-maturing amygdala neurons in humans and mice

$708,993
Shawn Sorrells · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · MH

Neural mechanisms underlying the antidepressant effects of sleep deprivation

$708,989
Philip Richard Gehrman · University Of Pennsylvania · R01 · FY2016 · MH

Structure and Function of Hetero-Multimeric Ligand-Gated Ion Channels

$708,974
Hiroyasu Furukawa · Cold Spring Harbor Laboratory · R01 · FY2024 · NS

Understanding socioeconomic disparities in perinatal risk: The role of epigenetic and transcriptional regulation in the placenta

$708,971
Gregory Evan Miller · Northwestern University · R01 · FY2019 · MD

Cellular and Molecular Substrates of Synaptic Plasticity

$708,958
Roger A Nicoll · University Of California, San Francisco · R37 · FY2010 · MH

Heart Failure in the Community

$708,914
Veronique L Roger · Mayo Clinic Rochester · R01 · FY2007 · HL

Opioids and Maternal Brain-Behavior Adaptation During the Early Postpartum

$708,909
James Edward Swain · State University New York Stony Brook · R01 · FY2022 · DA

Temperamental emotionality in preschoolers and risk for depression

$708,871
Daniel N Klein · State University New York Stony Brook · R01 · FY2018 · MH

Temperamental emotionality in preschoolers and risk for depression

$708,871
Daniel N Klein · State University New York Stony Brook · R01 · FY2015 · MH

Stress and Congestive Heart Failure: A mechanistic clinical trial

$708,817
Rachel Lampert · Yale University · R01 · FY2020 · HL

Blunted and Discordant Affect: A Transdiagnostic Construct in Psychopatholog

$708,779
Greg J Siegle · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · MH

Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems

$708,769
Ingrid A Binswanger · Kaiser Foundation Research Institute · R01 · FY2022 · DA

Using digital health to improve diet quality among adults at risk for cardiovasclar disease

$708,749
Gary G Bennett · Duke University · R01 · FY2022 · HL

Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity

$708,692
Scott L Letendre · University Of California, San Diego · R01 · FY2020 · DA

Racial and Socioeconomic Differences in Chronic Low Back Pain

$708,686
Burel R. Goodin · Washington University · R01 · FY2023 · MD

Hybrid Effectiveness-Implementation Trial of Massed PTSD Treatment in a Community Substance Use Program

$708,672
Denise Aimee Hien · Rutgers, The State Univ Of N.J. · R01 · FY2025 · MH

State social policy interventions for maternal health

$708,671
Kelli Stidham Hall · Tulane University Of Louisiana · R01 · FY2024 · HD

Enhancing Self-Management Support in Diabetes through Patient Engagement

$708,645
Danielle Marie Hessler · University Of California, San Francisco · R18 · FY2015 · DK

Developmental changes in reward responsivity: Associations with depression risk markers

$708,639
Thomas M Olino · Temple Univ Of The Commonwealth · R01 · FY2018 · MH

Determining the pathophysiology of pediatric arteriovenous malformation

$708,558
Arin K. Greene · Boston Children'S Hospital · R01 · FY2020 · HD

Disability and Health Outcomes in COPD

$708,555
University Of California San Francisco · R01 · FY2004 · HL

Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder.

$708,511
Michael Parks Bogenschutz · New York University School Of Medicine · R01 · FY2024 · AA